nach oben

Erschienen in:

17.01.2024 | Original Article

Clearance and nutrition in neonatal continuous kidney replacement therapy using the Carpediem™ system

verfasst von: Kim T. Vuong, Molly R. Vega, Lauren Casey, Sarah J. Swartz, Poyyapakkam Srivaths, Scott W. Osborne, Christopher J. Rhee, Ayse Akcan Arikan, Catherine Joseph

Erschienen in: Pediatric Nephrology | Ausgabe 6/2024

Einloggen, um Zugang zu erhalten

Abstract

Background

Infants with kidney failure (KF) demonstrate poor growth partly due to obligate fluid and protein restrictions. Delivery of liberalized nutrition on continuous kidney replacement therapy (CKRT) is impacted by clinical instability, technical dialysis challenges, solute clearance, and nitrogen balance. We analyzed delivered nutrition and growth in infants receiving CKRT with the Cardio-Renal, Pediatric Dialysis Emergency Machine (Carpediem™).

Methods

Single-center observational study of infants receiving CKRT with the Carpediem™ between June 1 and December 31, 2021. We collected prospective circuit characteristics, delivered nutrition, anthropometric measurements, and illness severity Score for Neonatal Acute Physiology-II. As a surrogate to normalized protein catabolic rate in maintenance hemodialysis, we calculated normalized protein nitrogen appearance (nPNA) using the Randerson II continuous dialysis model. Descriptive statistics, Spearman correlation coefficient, Mann Whitney, Wilcoxon signed rank, receiver operating characteristic curves, and Kruskal–Wallis analysis were performed using SAS version 9.4.

Results

Eight infants received 31.9 (22.0, 49.7) days of CKRT using mostly (90%) regional citrate anticoagulation. Delivered nutritional volume, protein, total calories, enteral calories, nPNA, and nitrogen balance increased on CKRT. Using parenteral nutrition, 90 ml/kg/day should meet caloric and protein needs. Following initial weight loss of likely fluid overload, exploratory sensitivity analysis suggests weight gain occurred after 14 days of CKRT. Despite adequate nutritional delivery, goal weight (z-score = 0) and growth velocity were not achieved until 6 months after CKRT start. Most (5 infants, 62.5%) survived and transitioned to peritoneal dialysis (PD).

Conclusions

Carpediem™ is a safe and efficacious bridge to PD in neonatal KF. Growth velocity of infants on CKRT appears delayed despite delivery of adequate calories and protein.

Graphical abstract

Nur mit Berechtigung zugänglich

Misurac J (2017) Chronic kidney disease in the neonate: etiologies, management, and outcomes. Semin Fetal Neonatal Med 22:98–103. https://doi.org/10.1016/j.siny.2016.09.003CrossRefPubMed

Sanderson KR, Warady BA (2020) End-stage kidney disease in infancy: an educational review. Pediatr Nephrol 35:229–240. https://doi.org/10.1007/s00467-018-4151-8CrossRefPubMed

Ranchin B, Plaisant F, Demède D et al (2021) Review: neonatal dialysis is technically feasible but ethical and global issues need to be addressed. Acta Paediatr 110:781–788. https://doi.org/10.1111/apa.15539CrossRefPubMed

Symons JM, Brophy PD, Gregory MJ et al (2003) Continuous renal replacement therapy in children up to 10 kg. Am J Kidney Dis 41:984–989. https://doi.org/10.1016/S0272-6386(03)00195-1CrossRefPubMed

Hepponstall M, Chan A, Monagle P (2017) Anticoagulation therapy in neonates, children and adolescents. Blood Cells Mol Dis 67:41–47. https://doi.org/10.1016/j.bcmd.2017.05.008CrossRefPubMed

Inder TE, Perlman JM, Volpe JJ (2018) Intracranial hemorrhage. In: Volpe J, Inder T, Darras B et al (eds) Volpe’s neurology of the newborn. Elsevier, Philadelphia, pp 593–622CrossRef

Garzotto F, Zanella M, Ronco C (2014) The evolution of pediatric continuous renal replacement therapy. Nephron Clin Pract 127:172–175. https://doi.org/10.1159/000363204CrossRefPubMed

Garzotto F, Vidal E, Ricci Z et al (2020) Continuous kidney replacement therapy in critically ill neonates and infants: a retrospective analysis of clinical results with a dedicated device. Pediatr Nephrol 35:1699–1705. https://doi.org/10.1007/s00467-020-04562-yCrossRefPubMed

Hay WW, Thureen P (2010) Protein for preterm infants: how much is needed? How much is enough? How much is too much? Pediatr Neonatol 51:198–207. https://doi.org/10.1016/S1875-9572(10)60039-3CrossRefPubMed

10.

Frondas-Chauty A, Simon L, Branger B et al (2014) Early growth and neurodevelopmental outcome in very preterm infants: impact of gender. Arch Dis Child Fetal Neonatal Ed 99:F366–F372. https://doi.org/10.1136/archdischild-2013-305464CrossRefPubMed

11.

Ehrenkranz RA, Dusick AM, Vohr BR et al (2006) Growth in the neonatal intensive care unit influences neurodevelopmental and growth outcomes of extremely low birth weight infants. Pediatrics 117:1253–1261. https://doi.org/10.1542/peds.2005-1368CrossRefPubMed

12.

Murphy HJ, Cahill JB, Twombley KE, Kiger JR (2018) Early continuous renal replacement therapy improves nutrition delivery in neonates during extracorporeal life support. J Ren Nutr 28:64–70. https://doi.org/10.1053/j.jrn.2017.06.008CrossRefPubMed

13.

Zappitelli M, Goldstein SL, Symons JM et al (2008) Protein and calorie prescription for children and young adults receiving continuous renal replacement therapy: a report from the Prospective Pediatric Continuous Renal Replacement Therapy Registry Group. Crit Care Med 36:3239–3245. https://doi.org/10.1097/CCM.0b013e31818f3f40CrossRefPubMed

14.

Wong Vega M, Juarez Calderon M, Tufan Pekkucuksen N et al (2019) Feeding modality is a barrier to adequate protein provision in children receiving continuous renal replacement therapy (CRRT). Pediatr Nephrol 34:1147–1150. https://doi.org/10.1007/s00467-019-04211-zCrossRefPubMed

15.

Ganesan MV, Annigeri RA, Shankar B et al (2009) The protein equivalent of nitrogen appearance in critically ill acute renal failure patients undergoing continuous renal replacement therapy. J Ren Nutr 19:161–166. https://doi.org/10.1053/j.jrn.2008.11.009CrossRefPubMed

16.

Macias WL, Alaka KJ, Murphy MH et al (1996) Impact of the nutritional regimen on protein catabolism and nitrogen balance in patients with acute renal failure. J Parenter Enteral Nutr 20:56–62. https://doi.org/10.1177/014860719602000156CrossRef

17.

Johnson RJ, Warady BA (2013) Long-term neurocognitive outcomes of patients with end-stage renal disease during infancy. Pediatr Nephrol 28:1283–1291. https://doi.org/10.1007/s00467-013-2458-zCrossRefPubMed

18.

Juarez-Congelosi M, Orellana P, Goldstein SL (2007) Normalized protein catabolic rate versus serum albumin as a nutrition status marker in pediatric patients receiving hemodialysis. J Ren Nutr 17:269–274. https://doi.org/10.1053/j.jrn.2007.04.002CrossRefPubMed

19.

Morse S, Groer M, Shelton MM et al (2015) A systematic review: the utility of the revised version of the score for neonatal acute physiology among critically ill neonates. J Perinat Neonatal Nurs 29:315–344. https://doi.org/10.1097/JPN.0000000000000135CrossRefPubMedPubMedCentral

20.

van Stralen KJ, Borzych-Dużalka D, Hataya H et al (2014) Survival and clinical outcomes of children starting renal replacement therapy in the neonatal period. Kidney Int 86:168–174. https://doi.org/10.1038/ki.2013.561CrossRefPubMed

21.

Fenton TR, Chan HT, Madhu A et al (2017) Preterm infant growth velocity calculations: a systematic review. Pediatrics 139:e20162045. https://doi.org/10.1542/peds.2016-2045CrossRefPubMed

22.

Simon L, Hanf M, Frondas-Chauty A et al (2019) Neonatal growth velocity of preterm infants: the weight Z-score change versus Patel exponential model. PLoS One 14:e0218746. https://doi.org/10.1371/journal.pone.0218746CrossRefPubMedPubMedCentral

23.

Sutherland SM, Davis AS, Powell D et al (2022) Kidney replacement therapy in low birth weight preterm newborns. Pediatrics 150:e2022056570. https://doi.org/10.1542/peds.2022-056570CrossRefPubMed

24.

Shaw V, Anderson C, Desloovere A et al (2023) Nutritional management of the infant with chronic kidney disease stages 2–5 and on dialysis. Pediatr Nephrol 38:87–103. https://doi.org/10.1007/s00467-022-05529-xCrossRefPubMed

25.

Shaw V, Polderman N, Renken-Terhaerdt J et al (2020) Energy and protein requirements for children with CKD stages 2–5 and on dialysis–clinical practice recommendations from the Pediatric Renal Nutrition Taskforce. Pediatr Nephrol 35:519–531. https://doi.org/10.1007/s00467-019-04426-0CrossRefPubMed

26.

Haffner D (2020) Strategies for optimizing growth in children with chronic kidney disease. Front Pediatr 8:399. https://doi.org/10.3389/fped.2020.00399CrossRefPubMedPubMedCentral

27.

Mehls O, Wühl E, Tönshoff B et al (2008) Growth hormone treatment in short children with chronic kidney disease. Acta Paediatr 97:1159–1164. https://doi.org/10.1111/j.1651-2227.2008.00845.xCrossRefPubMed

28.

Drube J, Wan M, Bonthuis M et al (2019) Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease. Nat Rev Nephrol 15:577–589. https://doi.org/10.1038/s41581-019-0161-4CrossRefPubMedPubMedCentral

29.

Mekahli D, Shaw V, Ledermann SE, Rees L (2010) Long-term outcome of infants with severe chronic kidney disease. Clin J Am Soc Nephrol 5:10–17. https://doi.org/10.2215/CJN.05600809CrossRefPubMedPubMedCentral

30.

Greenbaum LA, Muñoz A, Schneider MF et al (2011) The association between abnormal birth history and growth in children with CKD. Clin J Am Soc Nephrol 6:14–21. https://doi.org/10.2215/CJN.08481109CrossRefPubMedPubMedCentral

31.

Goldstein SL, Akcan-Arikan A, Alobaidi R et al (2022) Consensus-based recommendations on priority activities to address acute kidney injury in children: a modified Delphi consensus statement. JAMA Netw Open 5:e2229442. https://doi.org/10.1001/jamanetworkopen.2022.29442CrossRefPubMedPubMedCentral

32.

Nelms CL, Shaw V, Greenbaum LA et al (2021) Assessment of nutritional status in children with kidney diseases—clinical practice recommendations from the Pediatric Renal Nutrition Taskforce. Pediatr Nephrol 36:995–1010. https://doi.org/10.1007/s00467-020-04852-5CrossRefPubMed

33.

Young A, Brown LK, Ennis S et al (2021) Total body water in full-term and preterm newborns: systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 106:542–548. https://doi.org/10.1136/archdischild-2020-321112CrossRefPubMed

34.

Laakkonen H, Happonen J-M, Marttinen E et al (2010) Normal growth and intravascular volume status with good metabolic control during peritoneal dialysis in infancy. Pediatr Nephrol 25:1529–1538. https://doi.org/10.1007/s00467-010-1535-9CrossRefPubMedPubMedCentral

35.

Slagle CL, Riddle SL, McNelis K, Claes D (2022) Single-center experience on growth in infants born with end-stage kidney disease. J Ren Nutr 33:236–242. https://doi.org/10.1053/j.jrn.2022.09.007. (S1051227622001686)CrossRefPubMed

36.

Kritmetapak K, Peerapornratana S, Srisawat N et al (2016) The impact of macro-and micronutrients on predicting outcomes of critically ill patients requiring continuous renal replacement therapy. PLoS One 11:e0156634. https://doi.org/10.1371/journal.pone.0156634CrossRefPubMedPubMedCentral

37.

Kalantar-Zadeh K, Supasyndh O, Lehn RS et al (2003) Normalized protein nitrogen appearance is correlated with hospitalization and mortality in hemodialysis patients with Kt/V greater than 1.20. J Ren Nutr 13:15–25. https://doi.org/10.1053/jren.2003.50005CrossRefPubMed

38.

Iglesias SBDO, Leite HP, Meneses JFSE, De Carvalho WB (2007) Enteral nutrition in critically ill children: are prescription and delivery according to their energy requirements? Nutr Clin Pract 22:233–239. https://doi.org/10.1177/0115426507022002233CrossRef

39.

Ainsworth S, Furness J, Fenton A (2007) Randomized comparative trial between percutaneous longlines and peripheral cannulae in the delivery of neonatal parenteral nutrition. Acta Paediatr 90:1016–1020. https://doi.org/10.1111/j.1651-2227.2001.tb01357.xCrossRef

40.

Rico MP, Fernández Sarmiento J, Rojas Velasquez AM et al (2017) Regional citrate anticoagulation for continuous renal replacement therapy in children. Pediatr Nephrol 32:703–711. https://doi.org/10.1007/s00467-016-3544-9CrossRefPubMed

Titel: Clearance and nutrition in neonatal continuous kidney replacement therapy using the Carpediem™ system
verfasst von: Kim T. Vuong
Molly R. Vega
Lauren Casey
Sarah J. Swartz
Poyyapakkam Srivaths
Scott W. Osborne
Christopher J. Rhee
Ayse Akcan Arikan
Catherine Joseph
Publikationsdatum: 17.01.2024
Verlag: Springer Berlin Heidelberg
Erschienen in: Pediatric Nephrology / Ausgabe 6/2024
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-023-06237-w

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Clearance and nutrition in neonatal continuous kidney replacement therapy using the Carpediem™ system